An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
Uncategorized
Student loan policy may make medical school less accessible
Provisions in the One Big, Beautiful Bill Act capping student loans will make it more difficult for medical students — especially those from underserved populations — to become physicians, which may affect an already-severe workforce shortage.When the …
Uncategorized
Neuropathic corneal pain reduced in phase 2 trial of urcosimod
Neuropathic corneal pain was significantly reduced after 12 weeks of treatment with urcosimod in a phase 2 trial, according to a press release from Okyo Pharma.The FDA granted urcosimod, formerly called OK-101, fast track designation in May.Topline dat…
Uncategorized
EyePoint completes enrollment in phase 3 Duravyu trial
LONG BEACH, Calif. — EyePoint Pharmaceuticals completed enrollment in the LUCIA trial, its second phase 3 trial of Duravyu in patients with wet age-related macular degeneration, according to a press release.More than 400 patients have been enrolled in …
Uncategorized
Healio wins APEX award for story on diversity in clinical trials
Michela Cimberle, senior staff writer for Healio | OSN, won an APEX Award of Excellence for a 2024 exclusive story on diversity in clinical trials and efforts to improve health equality.Cimberle said she was inspired by a conversation she had with Amit…
Warby Parker Announces Second Quarter 2025 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the second quarter ended June 30, 2025. “It has been a bu…